Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
Zentalis Pharmaceuticals Community
NasdaqGM:ZNTL Community
0
Narratives
written by author
0
Comments
on narratives written by author
6
Fair Values set
on narratives written by author
Create a narrative
Zentalis Pharmaceuticals
Popular
Undervalued
Overvalued
Community Investing Ideas
There are no community narratives available.
Your Valuation for
ZNTL
ZNTL
Zentalis Pharmaceuticals
Your Fair Value
US$
Current Price
US$1.81
87.9% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-292m
290m
2015
2018
2021
2024
2025
2027
2030
Revenue US$290.2m
Earnings US$57.4m
Advanced
Set Fair Value